From the *Institut de Recerca Sant Joan de Deu, Barcelona, Spain
†CIBER de Epidemiología y Salud Pública CIBERESP, Madrid, Spain
‡Universitat Internacional de Catalunya, Barcelona, Spain
§Department of Molecular Microbiology, Clinical Laboratory, Hospital Sant Joan de Déu, Barcelona, Spain.
Accepted for publication August 9, 2020.
Supported by Roche Diagnostics and CIBER de Epidemiología y SaludPública (CIBERESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.
C.M.A. reports research grants to her institution from Pfizer, Biofire Diagnostics, BioMérieux, Alere and Genomica SAU, and compensation fees from Qiagen, Roche Diagnostics, and BioMérieux for scientific presentations in satellite symposiums outside the submitted work. P.B. reports compensation fees from Roche Diagnostics for scientific presentations in satellite symposiums outside the submitted work. The rest of authors report no conflict of interest.
P.B. acquired test result data, analyzed and interpreted data, prepared the first draft manuscript, and revised and approved the final version of the article. J.S. performed laboratory tests, acquired test result data, analyzed and interpreted data, and revised and approved the final version of the article. S.S. and A.G. analyzed and interpreted data, and approved the final version of the article. C.M.A. defined the study design, analyzed and interpreted data, and revised and approved the final version of the article.
Address for correspondence: Carmen Muñoz-Almagro, MD, PhD, Department of Molecular Microbiology, Clinical Laboratory, Hospital Sant Joan de Déu, P° Sant Joan de Déu, n° 2, 08950 Esplugues, Barcelona. E-mail: [email protected].
